Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease Treated with Canakinumab: Bayesian and Population Model-Based Analyses.
Cornelia Dunger-BaldaufPriscila NakasatoStephanie NovielloSarah WhelanBruno BiethPublished in: Rheumatology and therapy (2022)
The analyses presented support the similarity of clinical outcomes following treatment with canakinumab in patients with sJIA and AOSD.